# An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease

> **NCT00091845** · PHASE1 · TERMINATED · sponsor: **Sarepta Therapeutics, Inc.** · enrollment: 50 (estimated)

## Conditions studied

- West Nile Fever

## Interventions

- **DRUG:** AVI-4020 Injection

## Key facts

- **NCT ID:** NCT00091845
- **Lead sponsor:** Sarepta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** Due to limited pool of eligble WNV patients
- **Last updated:** 2009-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00091845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00091845, "An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00091845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*